11/19/2024 6:18 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 6:18 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 6:19 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 11:54 AM | Capital World Investors (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
11/12/2024 8:31 AM | Adage Capital Management, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024 1:34 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/04/2024 3:40 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
11/04/2024 11:00 AM | KalVista Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 6:00 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2024 3:05 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2024 3:06 PM | KalVista Pharmaceuticals (Issuer) Unkart Edward W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:07 PM | KalVista Pharmaceuticals (Issuer) Treanor Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:07 PM | KalVista Pharmaceuticals (Issuer) Stuart Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:08 PM | KalVista Pharmaceuticals (Issuer) Pereira Brian JG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:08 PM | Fairey William (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 3:32 PM | KalVista Pharmaceuticals (Issuer) Piekos Brian (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/11/2024 3:34 PM | KalVista Pharmaceuticals (Issuer) Piekos Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 7:31 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 3:39 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:24 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/26/2024 6:58 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 7:00 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:13 PM | KalVista Pharmaceuticals (Filer)
| Form DEFA14A | |
08/22/2024 3:17 PM | KalVista Pharmaceuticals (Filer)
| Form ARS | |
08/22/2024 3:08 PM | KalVista Pharmaceuticals (Filer)
| Form DEF 14A | |
08/21/2024 8:25 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 8:25 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 8:26 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/23/2024 3:23 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2024 11:15 PM | KalVista Pharmaceuticals (Filer)
| Form EFFECT | |
07/11/2024 3:49 PM | KalVista Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/28/2024 3:21 PM | KalVista Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2024 5:42 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:55 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:57 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:58 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:59 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 3:34 PM | Fairey William (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/22/2024 3:35 PM | Fairey William (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:37 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
03/08/2024 3:50 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:38 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 3:35 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
02/22/2024 12:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/21/2024 8:51 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:41 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:44 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:46 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:48 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:49 PM | KalVista Pharmaceuticals (Subject) TCG Crossover GP I, LLC (Filed by)
| Form SC 13D/A | |
02/16/2024 3:32 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:20 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:21 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:52 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 4:13 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
02/13/2024 8:11 AM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:20 AM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:23 AM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:06 AM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:08 AM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:55 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:30 PM | KalVista Pharmaceuticals (Subject) Saturn V Capital Management LP (Filed by)
| Form SC 13G | |
02/09/2024 8:16 AM | KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 7:11 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:38 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 6:07 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 7:24 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:02 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:04 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:26 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:57 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 5:05 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:24 PM | KalVista Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024 3:47 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:13 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:44 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:16 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023 4:12 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 12:33 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |